Literature DB >> 9024520

Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma.

M A Castello1, G Ragni, A Antimi, A Todini, G Patti, R Lubrano, A Clerico, A Calisti.   

Abstract

A giant cavernous hemangioma of the left arm with severe thrombocytopenia and consumptive coagulopathy was observed in a neonate. Initial treatment with prednisone, platelet transfusions, and clotting replacement failed to control the bleedings. The child was then treated with daily subcutaneous infusions of interferon alpha-2a. Coagulopathy rapidly improved and transfusions were drastically reduced. The hemangioma regressed progressively and disappeared after 4 months of treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024520     DOI: 10.1002/(sici)1096-911x(199703)28:3<213::aid-mpo12>3.0.co;2-f

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

Review 1.  The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils.

Authors:  Ekaterina Pylaeva; Stephan Lang; Jadwiga Jablonska
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

2.  Intralesional injection of triamcinolone acetonide for cavernous hemangiomas: A case report.

Authors:  Wen-Yan Wang; Luan-Hong Wang; Guang Huang; Zhen-Ying Lin; Han Lin
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

3.  Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.

Authors:  Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Takehiro Noda; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  BMC Cancer       Date:  2009-10-12       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.